Anthony (Tony) Mauro is Mylan’s Chief Commercial Officer (CCO) overseeing all of its commercial businesses around the world. As CCO, Mauro is responsible for leveraging Mylan’s diverse portfolio, pipeline and expansive commercial infrastructure to drive business growth across multiple markets and channels.
Mauro has been with Mylan for more than 20 years. He has served the company in several capacities of increasing responsibility. Most recently, he served as president of North America, successfully leading the company’s largest commercial business. Prior to that role, Mauro served as president of Mylan Pharmaceuticals Inc., the company's flagship generics division in the U.S.; chief operating officer of Mylan Pharmaceuticals ULC in Canada; vice president of North America Strategic Development; and vice president of North America Sales.
In 2012 and 2013, Mauro served as chairman of the board of directors for the U.S. Generic Pharmaceutical Association (GPhA), which represents the world's leading generic drug manufacturers and suppliers. Prior to that he served two consecutive terms as vice chairman of the board for GPhA, now known as the Association for Accessible Medicines.
Mauro is a member of the visiting committee at West Virginia University's Graduate School of Business and Economics. Mauro earned a bachelor's degree in business administration, with a specialization in finance, and a master's degree in business administration from West Virginia University.